Renowned Speakers

Jason D. Gardner

Louisiana State University Health Sciences Center, USA

Dharambir K Sanghera

Dharambir K Sanghera University of Oklahoma Health Sciences Center, USA

Zuzanna Kozielska

zuzanna kozielska obstetrics and gynaecology Germany

Dennis C. Bruemmer

Dennis C. Bruemmer University of Pittsburgh USA

Recommended Global Diabetes & Endocrinology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

HORMONES 2024

About Conference

Conference Series is pleasure to invite you to participate in 3rd International Summit on Hormonal Disorders to be held during October 14-15, 2024 at Madrid, Spain. Participants are encouraged to focus on the theme, "Exploring the impact of Hormonal Disorders". These events will serve as a platform for exchanging knowledge, advancements, and ideas in the Subject of Hormones, offering opportunities to learn about effective ways to improve healthcare outcomes and enhance medical technology.

THE HORMONES 2024 is designed for Endocrinologists, Diabetologists, Reproductive Endocrinologists, Surgeons, Physicians, Health Care Professionals, Professors, Medical Directors, and students actively engaged in this field. The conference will feature prompt keynote presentations, oral talks, poster presentations, video presentations, exhibitions, symposiums, workshops, and a Young Researcher’s Forum focusing on the latest treatments and innovative methods for Hormonal Disorders.

The conference is expected to cover a diverse range of topics, including new surgical techniques to treat the Disorders, technological advances, research findings, case studies, and discussions on healthcare policy. The primary objective is to bring together individuals sharing a common interest in this subject, facilitating the exchange of knowledge, ideas, and fostering collaboration in the field.

Sessions and Tracks

Track 01: Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by high levels of glucose (sugar) in the blood. It occurs when the body either does not produce enough insulin or cannot effectively use the insulin it produces. Insulin is a hormone produced by the pancreas that helps regulate blood sugar levels and facilitates the uptake of glucose into cells for energy.

American Association of Clinical Endocrinology (AACE) | International Society of Pediatric and Adolescent Diabetes (ISPAD) | Canadian Society of Endocrinology and Metabolism | Cushing's Support and Research Foundation (CSRF) | Addison's Disease Self-Help Group (ADSHG) (UK) | German Society of Endocrinology (DGE) | American Diabetes Association (ADA) | The Pituitary Society(USA)

Track 02: Type 1 Diabetes

This autoimmune condition occurs when the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the pancreas produces little to no insulin. Type 1 diabetes typically develops in childhood or adolescence, although it can occur at any age. People with type 1 diabetes require lifelong insulin therapy to manage their blood sugar levels.

Track 03: Type 2 Diabetes

In type 2 diabetes, the body becomes resistant to the effects of insulin or the pancreas does not produce enough insulin to meet the body's needs. This leads to elevated blood sugar levels. Type 2 diabetes is more common than type 1 and is often associated with lifestyle factors such as obesity, physical inactivity, and poor diet. It typically develops in adults, but increasingly affects children and adolescents due to rising obesity rates. Type 2 diabetes can often be managed with lifestyle modifications, oral medications, and/or insulin therapy.

Track 04: Gestational Diabetes

This type of diabetes occurs during pregnancy and usually resolves after childbirth. It is characterized by high blood sugar levels that develop during pregnancy in women who did not have diabetes before pregnancy. Gestational diabetes increases the risk of complications during pregnancy and delivery and may also increase the risk of type 2 diabetes later in life for both the mother and child.

Track 05: Hypothyroidism

Hypothyroidism is a common Hormonal disorder characterized by an underactive thyroid gland, which fails to produce enough thyroid hormone to meet the body's needs. Causes of hypothyroidism include autoimmune thyroiditis (Hashimoto's thyroiditis), thyroid surgery or radiation therapy, certain medications, congenital thyroid defects, and iodine deficiency. Symptoms of hypothyroidism can vary widely but may include fatigue, weight gain, sensitivity to cold, dry skin, hair loss, constipation, depression, muscle weakness, joint pain, and menstrual irregularities in women.

Track 06: Thyrotoxicosis

Thyrotoxicosis is a common endocrine disorder characterized by an overactive thyroid gland, leading to excessive production of thyroid hormones. The most common cause of hyperthyroidism is an autoimmune condition known as Graves' disease, where the body's immune system mistakenly attacks the thyroid gland, causing it to produce too much thyroid hormone. Symptoms of hyperthyroidism may include weight loss, increased appetite, rapid heartbeat (tachycardia), palpitations, sweating, heat intolerance, tremors, anxiety, irritability, fatigue, muscle weakness, and changes in menstrual patterns.

Track 07: Thyroid Nodules

Thyroid nodules are lumps or growths that develop within the thyroid gland. Most thyroid nodules are benign (non-cancerous) and do not cause symptoms. While the majority of thyroid nodules are harmless, some may cause symptoms such as difficulty swallowing, hoarseness, or visible neck swelling. Diagnosis of thyroid nodules typically involves imaging tests such as ultrasound, along with fine-needle aspiration biopsy to determine whether the nodule is benign or cancerous.

Track 08: Goiter

Goiter refers to the abnormal enlargement of the thyroid gland, causing swelling or protrusion in the neck. It can occur due to various reasons, including iodine deficiency, autoimmune thyroiditis (such as Hashimoto's thyroiditis), or the presence of thyroid nodules. Symptoms of goiter may include a visible swelling in the neck, difficulty swallowing or breathing, coughing, or hoarseness. Diagnosis of goiter involves physical examination, imaging tests (such as ultrasound), and blood tests to evaluate thyroid function and rule out underlying causes.

Track 09: Cushing's syndrome

Cushing's syndrome is a hormonal disorder characterized by prolonged exposure to high levels of cortisol, a steroid hormone produced by the adrenal glands. There are several possible causes of Cushing's syndrome, including This can occur due to adrenal tumors such as carcinomas that produce excess cortisol independent of normal regulatory mechanisms. Most cases of Cushing's syndrome result from overproduction of adrenocorticotropic hormone (ACTH) by a benign tumor (adenoma) in the pituitary gland. This tumor causes the adrenal glands to produce excess cortisol. In rare cases, tumors outside the pituitary or adrenal glands, such as in the lungs or pancreas, can produce ACTH, leading to increased cortisol production.

Track 10: Addison's Disease

Addison's disease, also known as primary adrenal insufficiency, is a rare but serious endocrine disorder characterized by insufficient production of hormones by the adrenal glands. The most common cause of Addison's disease is autoimmune destruction of the adrenal cortex. Symptoms of disease can be nonspecific and may include decreased appetite, abdominal pain, nausea, vomiting, diarrhea, hypotension, dizziness, salt craving, hyperpigmentation , and changes in mood or behavior.

Track 11: Polycystic ovary syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is a common hormonal disorder affecting people with ovaries, typically during their reproductive years. PCOS is characterized by a combination of symptoms related to hormonal imbalances and metabolic issues.The cause of PCOS is involves a combination of genetic, hormonal, and environmental factors.Symptoms of PCOS can vary widely among individuals and may include irregular periods, infertility, weight gain, acne, hirsutism, hair loss, and mood disturbances

Diagnosis of PCOS typically involves a combination of medical history, physical examination, blood tests to assess hormone levels (including androgens and insulin), and imaging studies such as pelvic ultrasound to evaluate the ovaries.

Track 12: Growth hormone deficiency

Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of growth hormone (GH) by the pituitary gland. Growth hormone deficiency can occur at any age, but it is most commonly diagnosed in childhood when it can lead to short stature and growth failure. In adults, GHD can cause a range of symptoms, including decreased muscle mass, increased body fat, fatigue, decreased bone density, impaired cognitive function, and reduced quality of life.

Track 13: Acromegaly

Acromegaly is a rare hormonal disorder caused by the overproduction of growth hormone (GH) in adulthood. It typically occurs due to a benign tumor (adenoma) of the pituitary gland, although in rare cases, it can result from tumors elsewhere in the body that produce growth hormone-releasing hormone (GHRH). Excess GH leads to abnormal growth of tissues and organs, resulting in characteristic physical changes such as enlargement of the hands, feet, and facial features. Other symptoms may include joint pain, enlarged organs (such as the heart), thickening of the skin, sleep apnea, fatigue, headaches, and vision problems.

Track 14: Hyperparathyroidism

Hyperparathyroidism is a condition characterized by over activity of the parathyroid glands, leading to excessive production of parathyroid hormone (PTH). In hyperparathyroidism, elevated levels of PTH cause an increase in calcium levels in the blood (hypercalcemia). This can lead to a variety of symptoms and complications, including, Bone loss, Digestive issues, Cognitive changes, Cardiovascular complications. Diagnosis of hyperparathyroidism involves blood tests to measure calcium and PTH levels, as well as imaging studies such as ultrasound or sestamibi scan to locate any abnormal parathyroid glands.

Track 15: Hypoparathyroidism

Hypoparathyroidism is a rare endocrine disorder characterized by insufficient production or activity of parathyroid hormone (PTH), resulting in low levels of calcium in the blood (hypocalcemia) and high levels of phosphate. Common causes of hypoparathyroidism include surgical removal of the parathyroid glands (such as during thyroid surgery), autoimmune destruction of the parathyroid glands (as in autoimmune polyendocrine syndrome), genetic disorders (such as DiGeorge syndrome), or injury to the parathyroid glands.

Track 16: Pituitary Adenomas

Pituitary adenomas are benign tumors that develop in the pituitary gland, a small gland located at the base of the brain. Despite being non-cancerous, pituitary adenomas can cause hormonal imbalances and disrupt normal pituitary function due to their size and location. Diagnosis of pituitary adenomas involves a combination of imaging studies, such as MRI or CT scans, to visualize the tumor, along with hormonal tests to assess hormone levels and identify any hormonal imbalances.

Track 17: Hypopituitarism

Hypopituitarism is a condition characterized by underactivity of the pituitary gland, resulting in insufficient production of one or more hormones normally secreted by the gland. The pituitary gland, often referred to as the "master gland," plays a crucial role in regulating hormone production and controlling various bodily functions. Causes of hypopituitarism can vary and may include: Pituitary tumors, Pituitary surgery or radiation therapy, Trauma, Infections or inflammation, Genetic factors, Hypopituitarism can affect multiple hormone axes controlled by the pituitary gland, leading to a wide range of symptoms depending on which hormones are deficient.

Benefits Of Participation

Why to Attend:

Our conference boasts a well-balanced lineup of speakers, addressing both broad and specific topics of interest. We aim to provide surgeons, specialists, nurses, technologists, and all professionals involved in the subject of Hormonal Disorders with an opportunity to delve into the complexity of diseases, discuss interventional procedures, explore new and advanced surgical practices, assess their efficiency and efficacy in treating various cases, and grasp local realities and practical constraints in improving patient care.

The Hormonal Disorders 2024 will be organized around the theme "Hormonal Disorders: Unraveling the Complexity" and will consist of 17 tracks designed to offer comprehensive sessions that explore the various Disorders within the Topic. This presents an exceptional opportunity to attract a significant number of participants, facilitating the sharing of information, data, and B2B meetings with industrialists and potential customers to showcase innovative products live and gain brand recognition at this event. Renowned speakers, the latest systems, and the most recent updates in Hormonal Disorders are key highlights of this conference. Additionally, it serves as a platform for a wide range of Doctors to interact with one another.

Targeted Audience:

Surgeons and Physicians

Diabetologists
Endocrinologists
Cardiologists
Reproductive Endocrinologists
Pediatric Endocrinologists
Clinical Laboratory Scientists
Medical Practitioners
Researchers and Academics
Medical Students and Trainees
International Delegates
Medical Colleges, Universities
Clinical Nurse Specialists

Benefits of speaker:

Our conferences offer the best platform for presenting your research through oral presentations.
Share your ideas with both eminent researchers and mentors.
Winners of the Young Scientist Award receive a recognition certificate and a memento.
We provide an opportunity for conference abstracts to be published in 10+10 additional languages, ensuring that each participant's abstract is published in their respective language.
Stay updated on the latest advancements in surgical techniques, technologies, and research.
Connect with fellow surgeons, specialists, and healthcare professionals.
Build collaborations, share experiences, and exchange knowledge.
Explore and learn about the latest surgical tools, equipment, and technologies.

Market Analysis

The global market for endocrine disorders testing anticipated to reach $18.2 billion by 2029, growing at CAGR 6.9% over the forecast period, driven by increasing incidence of endocrine disorders such as diabetes, thyroid disorders, and infertility, as well as rising healthcare awareness among the population, growing elderly population, and technological advancements.

The global market for endocrine disorders testing research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

To Collaborate Scientific Professionals around the World

Conference Date October 14-15, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Supported By

Journal of Steroids & Hormonal Science Journal of Endocrinology & Metabolic Syndrome Journal Of Obesity & Eating Disorders

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Hormonal Disorders

October 14-15, 2024 Madrid, Spain

Exploring the impact of Hormonal Disorders

Conference Series Conferences gaining more Readers and Visitors